Effect of mitochondrial translocator protein TSPO on LPS-induced cardiac dysfunction
This study elucidated the effect of TSPO in LICD, providing a new therapeutic strategy to down-regulate TSPO by administration of TSPO-PROTAC for the prevention and treatment of LICD.
Authors
- B H He (ORCID: https://orcid.org/0000-0001-6275-4877)
- Yu Han (ORCID: https://orcid.org/0000-0002-3369-7655)
- Tingting Shu (ORCID: https://orcid.org/0000-0002-3020-9329)
- Xingyue Li
- Xingbing Li
- Pedro A. José (ORCID: https://orcid.org/0000-0003-1507-7556)
- Dandong Fang (ORCID: https://orcid.org/0000-0003-0482-7753)
- Xiao Chen (ORCID: https://orcid.org/0000-0003-3088-3337)
- Yongjian Yang (ORCID: https://orcid.org/0000-0003-1268-166X)
- Chunyu Zeng (ORCID: https://orcid.org/0009-0009-5059-2159)
- Ming Tang (ORCID: https://orcid.org/0000-0003-1587-2584)
- Lintao Jiang
- Feng-Yuan Yang
Institutions
- Army Medical University (CN)
- George Washington University (US)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Daping Hospital (CN)
- Chengdu Military General Hospital (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Nanjing Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Journal of Advanced Research
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1016/j.jare.2024.10.004
- Citations
- 8
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation